Erratum. Insulin Access and Affordability Working Group: Conclusions and Recommendations. Diabetes Care 2018;41;1299–1311
- William T. Cefalu,
- Daniel E. Dawes,
- Gina Gavlak,
- Dana Goldman,
- William H. Herman,
- Karen Van Nuys,
- Alvin C. Powers,
- Simeon I. Taylor and
- Alan L. Yatvin,
- on behalf of the Insulin Access and Affordability Working Group
On page 1302 of the article cited above, the wording of the following sentence was incorrect: “In contrast, net prices received by the manufacturer increased at a more modest rate with CAGRs of 3–36%—more in line with the rate of inflation for the overall economy.” The sentence should read “In contrast, net prices received by the manufacturer increased at a more modest rate (3–36%) with CAGRs of 0.2–2.1%.”
The online version (https://doi.org/10.2337/dci18-0019) has been corrected to reflect this change.
- © 2018 by the American Diabetes Association.
http://www.diabetesjournals.org/content/license
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.
In this Issue
August 2018, 41(8)
Erratum. Insulin Access and Affordability Working Group: Conclusions and Recommendations. Diabetes Care 2018;41;1299–1311
